AI assistant
CALIX, INC — Director's Dealing 2025
Nov 4, 2025
31174_dirs_2025-11-03_9f275462-5e2f-4a8d-b9b7-78d80318f2da.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: CALIX, INC ((CALX))
CIK: 0001406666
Period of Report: 2025-10-30
Reporting Person: Weening Michael (Director, President & CEO)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-10-30 | Common Stock | M | 200000 | $7.84 | Acquired | 216117 | Direct |
| 2025-10-30 | Common Stock | S | 150000 | $64.628 | Disposed | 66117 | Direct |
| 2025-10-30 | Common Stock | S | 50000 | $67.5456 | Disposed | 16117 | Direct |
| 2025-11-03 | Common Stock | M | 74000 | $7.84 | Acquired | 90117 | Direct |
| 2025-11-03 | Common Stock | S | 74000 | $67.4203 | Disposed | 16117 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2025-10-30 | Stock Option (right to buy) | $7.84 | M | 200000 | Disposed | 2029-11-27 | Common Stock (200000) | Direct |
| 2025-11-03 | Stock Option (right to buy) | $7.84 | M | 74000 | Disposed | 2029-11-27 | Common Stock (74000) | Direct |
Footnotes
F1: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $64.55 to $65.00, inclusive. Full information on the number of shares sold at each sale price is available upon request.
F2: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $67.35 to $67.93, inclusive. Full information on the number of shares sold at each sale price is available upon request.
F3: The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $66.245 to $69.450, inclusive. Full information on the number of shares sold at each sale price is available upon request.
F4: 100% of the shares subject to the option were fully vested and exercisable on November 27, 2023.